High-dose ECV19 | Low-dose ECV19 | Placebo | |
---|---|---|---|
Characteristics: N | 100 | 100 | 29 |
Sex | |||
Male: no. (%) | 44 (44.0) | 62 (62.0) | 18 (62.1) |
Female: no. (%) | 56 (56.0) | 38 (38.0) | 11 (37.9) |
Age years (y) | |||
All (19–67 y): mean (SD) | 40.8 (12.5) | 42.0 (13.1) | 39.6 (10.9) |
19–34 y: no. (%) | 29 (29.0) | 36 (36.0) | 11 (37.9) |
35–64 y: no. (%) | 69 (69.0) | 62 (62.0) | 18 (62.1) |
65–67 y: no. (%) | 2 (2.0) | 2 (2.0) | 0 (0.0) |
BMI: mean (SD) | 23.8 (2.8) | 23.8 (3.0) | 22.8 (2.6) |